We are live on ! Find out more
HCA

Horan Capital Advisors Portfolio holdings

AUM $297M
1-Year Est. Return 9.75%
This Fund
S&P 500
This Quarter Est. Return
+3.35%
1 Year Est. Return
+9.75%
3 Year Est. Return
+26.64%
5 Year Est. Return
+133.08%
10 Year Est. Return
+209.33%
AUM
$149M
AUM Growth
-$9.34M
Cap. Flow
-$13M
Cap. Flow %
-8.72%
Top 10 Hldgs %
37.84%
Holding
266
New
2
Increased
9
Reduced
46
Closed
195
Avg Time Held
12.3 quarters
Top 10 Avg Time Held
7.3 quarters
Top 20 Avg Time Held
7.5 quarters

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$2.14M
2
DIS icon
Walt Disney
DIS
+$852K
3
CVS icon
CVS Health
CVS
+$808K
4
CTVA icon
Corteva
CTVA
+$452K
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$89.3K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.73%
2 Technology 12.54%
3 Financials 12.26%
4 Communication Services 12.04%
5 Healthcare 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
YUMC icon
251
Yum China
YUMC
$13.6B
– –
-145
Closed -$7K –
ZBH icon
252
Zimmer Biomet
ZBH
$17.5B
– –
-410
Closed -$51K –
ZTS icon
253
Zoetis
ZTS
$29.5B
– –
-570
Closed -$57K –
GAP
254
The Gap Inc
GAP
$8.18B
– –
-100
Closed -$3K –
NXGN
255
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
– –
-20
Closed – –
VIVO
256
DELISTED
Meridian Bioscience Inc
VIVO
– –
-350
Closed -$6K –
DISCK
257
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
– –
-166
Closed -$4K –
RDS.B
258
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
– –
-1,031
Closed -$66K –
KSU
259
DELISTED
Kansas City Southern
KSU
– –
-207
Closed -$24K –
PRSP
260
DELISTED
Perspecta Inc. Common Stock
PRSP
– –
-35
Closed -$1K –
GWPH
261
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-150
Closed -$25K –
INWK
262
DELISTED
InnerWorkings, Inc.
INWK
– –
-6,650
Closed -$24K –
RTN
263
DELISTED
Raytheon Company
RTN
– –
-700
Closed -$127K –
VSM
264
DELISTED
Versum Materials, Inc.
VSM
– –
-150
Closed -$8K –
UN
265
DELISTED
Unilever NV New York Registry Shares
UN
– –
-300
Closed -$17K –
CELG
266
DELISTED
Celgene Corp
CELG
– –
-20,618
Closed -$1.95M –

Similar funds

Horan Capital Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Horan Capital Advisors held 266 positions worth $149M, down 5.9% from $158M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Horan Capital Advisors withdrew a net $13M in Q2 2019, closing 195 positions and reducing 46 holdings. Its most notable exit was Celgene Corp, an estimated $1.95M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 25% a quarter earlier, followed by Technology and Financials.

Against the trend, Horan Capital Advisors opened a new position in Dow Inc worth $2M.

  • Horan Capital Advisors's largest Q2 2019 buy was Dow Inc: 40,578 shares worth $2M.
  • Horan Capital Advisors added most to Walt Disney in Q2 2019, an estimated $852K increase.
  • Horan Capital Advisors's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $820K.
  • Horan Capital Advisors fully exited Celgene Corp in Q2 2019, selling an estimated $1.95M.
  • Horan Capital Advisors's ten largest holdings make up 38% of its $149M portfolio in Q2 2019.
  • Horan Capital Advisors opened 2 new positions and closed 195 in Q2 2019.
  • Horan Capital Advisors's portfolio value fell 5.9% quarter-over-quarter to $149M.

Based on Horan Capital Advisors's 13F filing for Q2 2019, filed 26 Jul 2019.